The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127985281 12798528 1 I 20160927 20160930 20160930 EXP US-JNJFOC-20160929159 JANSSEN MIN MS, YAO J, KIM SJ. DEVELOPMENT OF A RETICULAR RASH IN A FEBRILE WOMAN: AN UNUSUAL CUTANEOUS PRESENTATION OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA. JAAD CASE REPORTS 01-MAY-2015;1/3:160-162. 59.00 YR A F Y 0.00000 20160930 OT US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127985281 12798528 1 PS DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE 1 Unknown D N 50718 LIPOSOME INJECTION
127985281 12798528 2 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Unknown D 0 UNSPECIFIED
127985281 12798528 3 SS ETOPOSIDE. ETOPOSIDE 1 Unknown D 0 UNSPECIFIED
127985281 12798528 4 SS VINCRISTINE VINCRISTINE 1 Unknown D 0 UNSPECIFIED
127985281 12798528 5 SS PREDNISONE. PREDNISONE 1 Unknown D 0 UNSPECIFIED
127985281 12798528 6 SS IFOSFAMIDE. IFOSFAMIDE 1 Unknown D 0 UNSPECIFIED
127985281 12798528 7 SS CARBOPLATIN. CARBOPLATIN 1 Unknown D 0 UNSPECIFIED
127985281 12798528 8 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Unknown D 0 UNSPECIFIED
127985281 12798528 9 SS DEXAMETHASONE. DEXAMETHASONE 1 Unknown D 0 UNKNOWN
127985281 12798528 10 SS CISPLATIN. CISPLATIN 1 Unknown D 0 UNSPECIFIED
127985281 12798528 11 SS BRENTUXIMAB BRENTUXIMAB VEDOTIN 1 Unknown D 0 UNSPECIFIED
127985281 12798528 12 SS ROMIDEPSIN ROMIDEPSIN 1 Unknown D 0 UNSPECIFIED

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127985281 12798528 1 Angioimmunoblastic T-cell lymphoma
127985281 12798528 2 Angioimmunoblastic T-cell lymphoma
127985281 12798528 3 Angioimmunoblastic T-cell lymphoma
127985281 12798528 4 Angioimmunoblastic T-cell lymphoma
127985281 12798528 5 Angioimmunoblastic T-cell lymphoma
127985281 12798528 6 Angioimmunoblastic T-cell lymphoma
127985281 12798528 7 Angioimmunoblastic T-cell lymphoma
127985281 12798528 8 Angioimmunoblastic T-cell lymphoma
127985281 12798528 9 Angioimmunoblastic T-cell lymphoma
127985281 12798528 10 Angioimmunoblastic T-cell lymphoma
127985281 12798528 11 Angioimmunoblastic T-cell lymphoma
127985281 12798528 12 Angioimmunoblastic T-cell lymphoma

Outcome of event

Event ID CASEID OUTC COD
127985281 12798528 DE
127985281 12798528 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127985281 12798528 Cardio-respiratory arrest
127985281 12798528 Clostridial sepsis
127985281 12798528 Hypotension
127985281 12798528 Off label use
127985281 12798528 Product use issue

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found